Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection.
Kinnear
Gillian
G
Nuffield Department of Surgical Sciences, Transplantation Research Immunology Group, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Wood
Kathryn J
KJ
Marshall
Diane
D
Jones
Nick D
ND
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002455:Cell Division; D002470:Cell Survival / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology*; D007519:Isoantigens / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D053262:Receptors, OX40 / Q000276:immunology*; D016038:Skin Transplantation / Q000473:pathology*; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
D007519:Isoantigens; D053262:Receptors, OX40; D013936:Thymidine